Clinical trials: Heparin-induced Thrombocytopenia, open to volunteers
Heparin-induced Thrombocytopenia, HIT
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
The investigators would like to analyze platelet/leukoplak activation, quantify and morphologically characterize these aggregates using in vitro analysis, directly on whole blood from adult patients with suspected HIT.
- Conditions
- Heparin-induced Thrombocytopenia, HIT, Platelet Activation, Platelets
- Trial name
- HITSTREAM (NCT06033300)
- Testing
- blood sample
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Centre Hospitalier Universitaire, Amiens
Heparin-induced Thrombocytopenia
Cangrelor As Treatment for Cardiac Surgery Associated With Heparin Induced Thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is a rare but serious immune complication of heparin exposure that paradoxically increases the risk of thrombosis.
- Trial name
- CATCH-IT (NCT07817680)
- Where
- France
- Volunteers
- 132 people
- Sponsor
- Société Française d'Anesthésie et de Réanimation